New drug shows promise in preventing muscle loss amid GLP-1 boom

Apitegromab reduced muscle loss by more than half when used with tirzepatide in an early clinical trial. The findings raise hopes of protecting muscle health as GLP-1 medicines gain ground for weight loss and diabetes.